Cargando…

Stromal CEACAM1 expression regulates colorectal cancer metastasis

Colorectal cancer metastasis to Ceacam1-/- livers is significantly impaired, compared with wild type livers, due to decreased endothelial cell survival, reduced tumor cell proliferation, diminished immune infiltration and altered chemokine expression. Ceacam1-/- myeloid-derived suppressor cells dimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arabzadeh, Azadeh, Beauchemin, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494647/ https://www.ncbi.nlm.nih.gov/pubmed/23170281 http://dx.doi.org/10.4161/onci.20735

Ejemplares similares

COX2 regulation of breast cancer bone metastasis
por: Karavitis, John, et al.
Publicado: (2013)

Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis
por: Eiró, Noemi, et al.
Publicado: (2013)

Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016)

ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2018)

A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020)

DDR1 inhibition as a new therapeutic strategy for colorectal cancer
por: Sirvent, Audrey, et al.
Publicado: (2018)

The colorectal cancer immune paradox revisited
por: Angelova, Mihaela, et al.
Publicado: (2015)

Macrophages: Good guys in colorectal cancer
por: Edin, Sofia, et al.
Publicado: (2013)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Personalized peptide vaccination for advanced colorectal cancer
por: Sasada, Tetsuro, et al.
Publicado: (2015)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020)

TAM macrophages promote growth and metastasis within the cancer ecosystem
por: Zarif, Jelani C, et al.
Publicado: (2014)

FSTL1 promotes bone metastasis by causing immune dysfunction
por: Kudo-Saito, Chie
Publicado: (2013)

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis
por: Hirt, Christian, et al.
Publicado: (2013)

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
por: Slaney, Clare Y., et al.
Publicado: (2013)

Toll-like receptor genetic variants and colorectal cancer
por: Weber, Alexander NR, et al.
Publicado: (2014)

Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer
por: Iskar, Murat, et al.
Publicado: (2015)

The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy
por: Talebian, Fatemeh, et al.
Publicado: (2012)

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012)

The CCL5/CCR5 axis promotes metastasis in basal breast cancer
por: Velasco-Velázquez, Marco, et al.
Publicado: (2013)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Targeting copper metabolism to defeat KRAS-driven colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020)

Alerting the immune system via stromal cells is central to the prevention of tumor growth
por: Issazadeh-Navikas, Shohreh
Publicado: (2013)

Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
por: Kesselring, Rebecca, et al.
Publicado: (2012)

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
por: Thibaudin, Marion, et al.
Publicado: (2023)

MIF: metastasis/MDSC-inducing factor?
por: Simpson, Kendra D., et al.
Publicado: (2013)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition
por: Popova, Semiramis A., et al.
Publicado: (2018)

Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors
por: Edris, Badreddin, et al.
Publicado: (2013)

BORA-dependent PLK1 regulation: A new weapon for cancer therapy?
por: Cirillo, Luca, et al.
Publicado: (2016)

Epigenetic suppression of FBXL7 promotes metastasis
por: Moro, Loredana, et al.
Publicado: (2020)

Tumor conditioned media from colorectal cancer patients inhibits dendritic cell maturation
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)

Tumor spread or siege immunity: dissemination to distant metastasis or not
por: Bindea, Gabriela, et al.
Publicado: (2021)

Combining targeted therapy with immunotherapy (interferon-α): Rational, efficacy in gastrointestinal stromal tumor model and implications in other malignancies
por: Chen, Lei L., et al.
Publicado: (2012)

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
por: Hurchla, Michelle A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n6d2vtt8c2lliacbco9j236rn6